179 results on '"Iliakis, Panagiotis"'
Search Results
2. Unravelling the effect of renal denervation on glucose homeostasis: more questions than answers?
3. Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand?
4. Transcatheter Structural Heart Disease Interventions and Concomitant Left Atrial Appendage Occlusion: A State of the Art Review
5. Management of dyslipidemia in coronary artery disease: the present and the future
6. 7-day Aktiia bracelet vs 24 h ABPM study: more questions than answers?
7. ANOCA updated: From pathophysiology to modern clinical practice
8. LOX-1 Receptor: A Diagnostic Tool and Therapeutic Target in Atherogenesis
9. Coronary sinus narrowing therapy: A “Reducer” for angina and beyond
10. A network meta-analysis of the antithrombotic strategies in patients with atrial fibrillation and percutaneous coronary interventions: Focus on bleeding
11. Left ventricular mass versus pulse wave velocity as predictors of coronary artery disease in hypertensive patients: data from a 6-year-follow-up study
12. Modulating Sympathetic Nervous System With the Use of SGLT2 Inhibitors: Where There Is Smoke, There Is Fire?
13. Joint ESH excellence centers' national meeting on renal sympathetic denervation: A Greek experts’ survey
14. Renal Denervation in Heart Failure Treatment: Data for a Self-Fulfilling Prophecy.
15. Hypothermia for Cardioprotection in Acute Coronary Syndrome Patients: From Bench to Bedside.
16. Atrial Functional Mitral Regurgitation: From Diagnosis to Current Interventional Therapies.
17. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients Following Acute Coronary Syndromes: From Lipid Lowering and Plaque Stabilization to Improved Outcomes.
18. EPLERENONE VS IRBESARTAN AS FIRST LINE THERAPY IN OBESE HYPERTENSIVE PATIENTS: PRELIMINARY RESULTS OF HEBRO TRIAL IN ECHOCARDIOGRAPHIC DIASTOLIC FUNCTION INDEXES
19. THE ROLE OF RIGHT VENTRICLE FUNCTIONALITY IN THE CARDIOPULMONARY STATUS OF HYPERTENSIVE PATIENTS HOSPITALIZED FOR SARS-COV-2 INFECTION
20. THE INTERPLAY BETWEEN SYMPATHETIC NERVOUS SYSTEM OVERACTIVITY, BLOOD PRESSURE LEVELS AND NON-ALCOHOLIC FATTY LIVER DISEASE IN HYPERTENSIVE PATIENTS
21. EPLERENONE VS IRBESARTAN AS FIRST LINE THERAPY IN OBESE HYPERTENSIVE PATIENTS: PRELIMINARY RESULTS OF HEBRO TRIAL IN AMBULATORY BLOOD PRESSURE MEASUREMENTS
22. PREVALENCE AND PROGNOSTIC VALUE OF T-WAVE INVERSION IN HYPERTENSIVE PATIENTS: A 5-YEAR FOLLOW-UP STUDY
23. PREVALENCE AND ASSOCIATED PROGNOSIS OF ELECTROCARDIOGRAPHIC FINDINGS IN HYPERTENSIVE PATIENTS. AN ANALYSIS OF A 5-YEAR FOLLOW-UP STUDY
24. Renal Nerve Ablation
25. Transcatheter Structural Heart Interventions in the Acute Setting: An Emerging Indication.
26. Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus
27. Unravelling the effect of renal denervation on glucose homeostasis: more questions than answers?
28. Anticoagulation Status and Left Atrial Appendage Occlusion Indications in Hospitalized Cardiology Patients with Atrial Fibrillation: A Hellenic Cardiorenal Morbidity Snapshot (HECMOS) Sub-Study
29. Transcatheter Tricuspid Valve Interventions: A Triumph for Transcatheter Procedures?
30. HELLENIC CARDIORENAL MORBIDITY SNAPSHOT (HECMOS). HIGH PREVALENCE OF DIFFICULT-TO-CONTROL HYPERTENSION IN CARDIOLOGY INPATIENTS WITH COMORBIDITIES
31. NET CLINICAL BENEFIT OF DIRECT ORAL ANTICOAGULANTS IN ATRIAL FIBRILLATION PATIENTS WITH OR WITHOUT DIABETES MELLITUS: A META-ANALYSIS OF OUTCOME TRIALS
32. Long-term efficacy and safety of renal denervation: an update from registries and randomised trials.
33. Coronary sinus reducer in an aneurysmatic coronary sinus: angina relief in challenging anatomies?
34. PS-C16-12: IS ARTERIAL HYPERTENSION A MODIFIER OF CARDIOPULMONARY EXERCISE TEST AND ECHOCARDIOGAPHIC FINDINGS AFTER HOSPITALIZATION FOR SARS-COV-2?
35. PS-C28-5: ROLE OF SYMPATHETIC NERVOUS SYSTEM IN ATTENDED AND UNATTENDED BP LEVELS IN ESSENTIAL HYPERTENSION
36. PS-C09-1: CORRELATION OF SYMPATHETIC NERVOUS SYSTEM ACTIVITY AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
37. SYMPATHETIC NERVOUS SYSTEM ACTIVITY IN ATTENDED AND UNATTENDED BP MEASUREMENTS: NAVIGATING THE UNCHARTED
38. CARDIOPULMONARY EXERCISE TEST AND ECHOCARDIOGAPHIC FINDINGS IN HOSPITALISED POST SARS-COV-2 PATIENTS: THE EFFECT OF ARTERIAL HYPERTENSION
39. SYSTOLIC VERSUS DIASTOLIC BLOOD PRESSURE AS PREDICTORS OF CARDIOVASCULAR EVENTS AMONG TREATED HYPERTENSIVE PATIENTS: A 6-YEAR PROSPECTIVE STUDY
40. MobiusHD Device
41. SYMPATHETIC NERVOUS SYSTEM ACTIVITY AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
42. EPLERENONE VS IRBESARTAN AS FIRST LINE THERAPY IN OBESE HYPERTENSIVE PATIENTS: PRELIMINARY RESULTS FROM HEBRO STUDY
43. Profile and management of hypertensive urgencies and emergencies in the emergency cardiology department of a tertiary hospital: a 12-month registry
44. Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus
45. Isolated diastolic vs. systolic hypertension phenotypes and outcomes: prospective cohort of newly diagnosed individuals with hypertension
46. Joint ESH excellence centers' national meeting on renal sympathetic denervation: A Greek experts' survey
47. Left ventricular mass versus pulse wave velocity as predictors of coronary artery disease in hypertensive patients: data from a 6-year-follow-up study
48. Isolated diastolic vs. systolic hypertension phenotypes and outcomes: prospective cohort of newly diagnosed individuals with hypertension
49. Effects of Sympathetic Denervation in Metabolism Regulation: A Novel Approach for the Treatment of MASLD?
50. SYMPATHETIC NERVE ACTIVITY CHANGES FOLLOWING ACUTE EXPOSURES TO ELECTRONIC AND TOBACCO CIGARETTE SMOKING IN HUMANS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.